AJP - Regu Information on EB 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Regul Integr Comp Physiol 294: R895-R904, 2008. First published January 9, 2008; doi:10.1152/ajpregu.00521.2007
0363-6119/08 $8.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
294/3/R895    most recent
00521.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mewe, M.
Right arrow Articles by Bauer, C. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mewe, M.
Right arrow Articles by Bauer, C. K.

NEUROHUMORAL CONTROL OF CARDIOVASCULAR FUNCTION

Erg K+ channels modulate contractile activity in the bovine epididymal duct

Marco Mewe,1 Iris Wulfsen,2 Anna M. E. Schuster,1 Ralf Middendorff,3 Günter Glassmeier,1 Jürgen R. Schwarz,4 and Christiane K. Bauer1

Institutes of 1Vegetative Physiology and Pathophysiology and 2Pharmacology for Pharmacists, University Medical Center Hamburg-Eppendorf, Hamburg; 3Institute of Anatomy and Cell Biology, Justus-Liebig-University of Giessen, Giessen; and 4Center for Molecular Neurobiology Hamburg, Hamburg, Germany

Submitted 19 July 2007 ; accepted in final form 4 January 2008


   ABSTRACT
TOP
 ABSTRACT
METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
The expression and functional role of ether-à-go-go-related gene (erg) K+ channels were examined in the bovine epididymal duct. Sperm transit through the epididymal duct relies on spontaneous phasic contractions (SC) of the peritubular smooth muscle wall. Isometric tension studies revealed SC-enhancing effects of the erg channel blockers E-4031, dofetilide, cisapride, and haloperidol and SC-suppressing effects of the activator NS-1643. In the corpus epididymidis, EC50 values of 32 nM and 8.3 µM were determined for E-4031 and NS-1643, respectively. E-4031 was also able to elicit contraction in epithelium-denuded corpus segments, which lacked SC. In the cauda region, E-4031 and NS-1643 exerted effects on agonist-induced contraction similar to those observed in the proximal duct. Experiments with nifedipine and thapsigargin suggested that the excitatory effects of E-4031 depended mainly on external calcium influx and not on intracellular calcium release. Western blot and RT-PCR assays revealed the expression of both, erg1a and erg1b, in all duct regions. Because erg1b appears to predominate in the epididymal duct, patch-clamp experiments were performed on heterologously expressed erg1b channels to investigate the sensitivity of this splice variant to NS-1643. In contrast to its effects on erg1a, NS-1643 induced a concentration-dependent current increase mainly due to a marked leftward shift in erg1b channel activation by ~30 mV at 10 µM, explaining the inhibitory effect of the drug on epididymal SC. In summary, these data provide strong evidence for a physiological role of erg1 channels in regulating epididymal motility patterns.

epididymis; voltage-gated potassium channel; motility; smooth muscle; Kv11 ether-à-go-go-related gene

IN SMOOTH MUSCLES, voltage-gated K+ (Kv) channels play an important role in the control of contraction by contributing to the maintenance of the resting membrane potential and excitability (see Ref. 17 for review). Whereas in skeletal muscle cells the resting potential is mediated by classical inward-rectifying K+ channels, in smooth muscle cells (SMC), ether-à-go-go-related gene (erg) K+ channels are often involved (see Ref. 34 for review). Three erg channels have been cloned [erg1 (39), erg2, and erg3 (35); Kv11.1–3], forming a subfamily of the ether-à-go-go Kv channels. There is accumulating evidence that erg1 channels modulate the electrical and contractile activities in smooth muscle and heart, whereas erg2 and erg3 are suggested to be widely "brain-specific" (35). Distinctive features of erg currents are marked inward rectification, a high sensitivity to methanesulfonanilides such as the class III antiarrhythmic agent E-4031, and an increased conductance in high extracellular K+ (31, 36, 38). Recently, a specific activator of the human ortholog of erg1 (HERG) channels, 1,3-bis-(2-hydroxy-5-trifluoromethyl-phenyl)-urea (NS-1643), was described (11), which mainly acts via reduced channel inactivation (4).

The best-known function of an erg1 current is its contribution to the repolarization of the cardiac action potential (31). E-4031-sensitive currents have also been detected in SMC of the esophagus (1), portal vein (28), gallbladder (29), stomach (27) and intestine (8, 18, 20). It is assumed that, in SMC, erg currents serve the function of threshold currents; a pharmacological block of erg channels depolarizes the membrane potential, which is correlated with muscle contraction (see Ref. 34 for review). Within the intestinal musculature, erg channels are concentrated on the interstitial cells of Cajal and may play a crucial role in regulating their pacemaker frequency (41). Likewise, multiple erg1 isoforms may constitute the molecular basis of pacemaker activity in sinoatrial node myocytes (5).

In the bull, passage of sperm through the epididymal duct occurs by means of spontaneous (caput and corpus region) and induced (cauda) contractions of peritubular SMC (23). In the present study, the functional impact of erg channels on epididymal contractile activity was investigated. Using tension studies, RT-PCR, and immunological analyses, we demonstrate expression and functional activity of erg1 channels in SMC of all regions of the epididymal duct. This finding, in conjunction with the newly described pharmacological properties of heterologously expressed erg1b channels, suggests that erg1 currents form a crucial determinant of epididymal SMC membrane excitability and therefore sperm transport.


   METHODS
TOP
 ABSTRACT
 METHODS
RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Tissue preparation. Bovine epididymal tissue was obtained from sexually mature bulls in a local slaughterhouse. The epididymides were removed after exsanguination and immediately placed in ice-cold Ca2+-free Hanks' balanced salt solution (GIBCO-BRL, Karlsruhe, Germany) for transport to the laboratory. Freshly prepared tissue samples of different regions of the epididymis [caput-corpus-cauda (22)] were fixed in Bouin's fluid for 24 h at 20°C for immunohistochemical analyses or frozen in liquid nitrogen for RT-PCR and Western blot experiments. For tension studies, segments of the epididymal duct were separated by carefully dissecting the surrounding tissue. For isolated muscle wall preparations, the epididymal epithelium was removed by perfusion of duct segments with 1% Triton X-100 (Merck-Calbiochem, Darmstadt, Germany) in PBS for 3 min using a Hamilton-syringe as described previously (23). Until use in tissue bath assays, the segments were stored in Dulbecco's minimal essential medium (DMEM; GIBCO) at 4°C. For positive controls, Lewis rats weighing 300–350 g were used. The epididymides were quickly excised after anesthetizing the animals with an intraperitoneal injection of sodium thiopenthal (100 mg/kg body wt) and killing them by exsanguination. Animal care and experimental procedures were reviewed and approved by the animal welfare committee of the University Medical Center Hamburg-Eppendorf (UKE).

Cell culture. HEK-293 and Chinese hamster ovary (CHO) cells were cultured in DMEM (GIBCO) supplemented with 1% penicillin-streptomycin-glutamine (GIBCO) and 10% FCS (Biother, Kelkheim, Germany) at 37°C in a humidified incubator (95% air-5% CO2). The culture medium was changed every 2–3 days, and the cells were passaged when they reached confluence.

Heterologous expression. HEK-293 cells were plated on poly-D-lysine (Sigma, Deisenhofen, Germany)-coated glass cover slips in 35-mm plastic culture dishes (Nunc) and microinjected with an Eppendorf Transjector 5246 (Eppendorf) with cDNA encoding rat erg1b (20 ng/µl; GenBank database acc. no. AY669863; see Ref. 12) cloned into the pcDNA3 vector (Invitrogen, Karlsruhe, Germany). To allow detection of successfully expressing cells, 10 ng/µl enhanced green fluorescent protein-N1 (Clontech, Heidelberg, Germany) was coexpressed. For immunological assays, CHO cells were plated on 14-cm plastic culture dishes and transfected with rerg1a (30 µg/plate; acc. no. Z96106; see Ref. 3) or rerg1b (30 µg/plate) using lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions.

Tension studies. Segments of different regions of the epididymal duct were mounted on two hooks in a double-jacketed organ bath (volume, 15 ml) filled with modified Krebs bicarbonate Ringer (KBR). Isometric contractions were measured at 33–34°C using a SG4–90 force-displacement transducer (Hugo Sachs, Freiburg, Germany). The output of the transducer was digitized at 0.5 Hz. Data collection was carried out using the BIOPAC MP35 data acquisition unit and the Biopac Student Lab PRO software (Biopac Systems, Santa Barbara, CA). Further data processing was performed with Excel (Microsoft, Redmond, WA) and Sigma Plot 7.101 (SPSS, Chicago, IL). Segments from the cauda were stretched incrementally to a preload tension of ~10 mN, and segments from the proximal duct regions (caput and corpus) were stretched to a preload tension of ~6 and 3 mN in the case of Triton X-100-pretreated material. Preparations were allowed to equilibrate for 60 min and to relax to a steady-state resting tension. Contraction frequency and amplitude were averaged over periods of 5 min before and after application of the substances.

RT-PCR. RNAs were extracted from the frozen tissues using RNAzol B (AGS, Heidelberg, Germany). Total RNA (1 µg) was employed for oligo(dT)-primed reverse transcription using Moloney murine leukemia virus reverse transcriptase (Invitrogen). The cDNAs were amplified with 1.25 units of Taq DNA polymerase (Stratagene, Amsterdam, Netherlands), 1.5 mM MgCl2, and 0.2 mM of each dNTP in 50 µl reaction assays using 5 pmol of forward and reverse oligonucleotide primers specific for the different bovine erg (b-erg) family members. For amplification, a predenaturation step at 94°C for 1 min was used followed by 40 cycles consisting of three temperature steps (first step: 94°C; second step: annealing temperature different for each primer pair; third step: 72°C; each temperature step lasted for 1 min) terminated by an elongation step at 72°C for 5 min. The annealing temperature was calculated for every primer pair from the G/C and A/T content of the oligonucleotide primers used in the reaction. Amplified DNA fragments were analyzed by agarose gel electrophoresis and sequencing. For the PCR amplifications, the following oligonucleotide primer sequences were employed (with the GenBank database accession nos. in brackets): b-erg1: nucleotides 31947–34144 (acc. no. NW_001494963 region 249880–284452): forward 5'-GGGTGGGGACCCCCTGACCG-3' and reverse 5'-GTCTGAGCCATGTCTGTGCA-3'; b-erg1a: nucleotides 26–355 (acc. no. NM_001099101): forward 5'-ATGCCGGTGCGGAGGGGCCA-3' and reverse 5'-CACCAGGCACAGGAAGCAGC-3'; b-erg1b: nucleotides 24974–27976 (acc. no. NW_001494963 region 249880–284452): forward 5'-ATGGCGGCCCCGTTGGGGAA-3' and reverse 5'-GCTTCCGGGCCACACGTACC-3'; b-erg2: nucleotides 542–836 (acc. no. XM_867795): forward 5'-GGTCGGGGGCACAGGGGCCT-3' and reverse 5'-CCTTGAATGGGCTGTAGTGC-3'; and b-erg3 nucleotides 85492–100676 (acc. no. NW_001494594 region 42079–267990): forward 5'-AACAAAAGAAAGCTGCAGCC-3' and reverse 5'-AACTTTGGGCGCAATAATGG-3'. Analysis using H2O instead of template served as negative control.

Western blotting. Membrane preparations of the bovine and rat epididymis as well as rat erg1a- or rerg1b-overexpressing CHO cells were prepared as follows. Tissues or cells were washed with cold PBS, collected, and homogenized in lysis buffer [25 mM Tris·HCl, 250 mM sucrose, 20 mM EDTA; protease inhibitors: 2 µg/ml leupeptin, aprotinin, and pepstatin A (Sigma), 0.1 mM phenylmethylsulfonyl fluoride (Sigma), 2 mM Na3O4V (Merck-Calbiochem); pH 7.2] on ice by the use of a glass-Teflon hand homogenizer (Braun, Melsungen, Germany). After incubation on ice for 10 min, samples were centrifuged for 5 min at 800 g at 4°C. Cell debris was removed, and the supernatant was centrifuged again for 30 min at 48,000 g. The pellets containing the cell membranes were resuspended in lysis buffer and stored at –80°C until SDS-PAGE separation and immunoblotting. Cells and tissue samples (50 µg) were fractionated on 10% SDS-PAGE and transferred to nitrocellulose membranes. Membranes were blocked with 5% lowfat milk powder in buffer containing 20 mM Tris, pH 7.5, 150 mM NaCl, 0.05% Tween 20 and then incubated with the specific antibody for erg1 (Chemicon, Hampshire, UK) in a 1:1,000 dilution overnight. The anti-erg1 antibody is targeted against the COOH terminus of HERG1 (amino acids 1145–1159), and recognizes bands at 175/205 and 135/165 kDa (representing glycosylated and deglycosylated erg1a, respectively) as well as at 95 kDa (representing erg1b) (30). Detection of immunoreactivity was carried out with the ECL Plus Western blotting detection system (Amersham Pharmacia, Freiburg, Germany).

Immunohistochemistry. Immunohistochemical analyses were performed essentially as described previously (25). In brief, paraffin sections (6 µm) were mounted on chrome gelatin-coated slides and incubated with the rabbit polyclonal anti-erg1 antibody (1:100) overnight. For visualization of immunoreactivity, a combination of the peroxidase-antiperoxidase technique and the avidin-biotin-peroxidase complex method was used (6). Biotinylated anti-rabbit IgG (Dako, Hamburg, Germany) was used as secondary antibody. Peroxidase activity was visualized by the nickel glucose oxidase technique. For negative controls, the primary antibody was omitted to indicate any nonspecific binding of the secondary antibody.

Electrophysiology. Membrane currents in erg1b-expressing HEK-293 cells were recorded in the conventional and the nystatin-perforated-patch whole cell configuration of the patch-clamp technique (10, 13). The patch electrodes were made from 1.5-mm-diameter borosilicate glass capillaries with resistances of 2.5–4 M{Omega}. Data were low-pass filtered at 3 kHz and compensated for both fast- and slow-capacity transients before the pulse protocols. The access resistance ranged between 6 and 29 M{Omega}, and series resistance compensation was as high as possible (60–85%). Data were corrected for the liquid junction potential error in perforated-patch experiments (~12 mV), but not in conventional whole cell experiments (~4 mV). All experiments were performed at room temperature. Cells were continuously perfused with 2 ml/min Ringer solution using a peristaltic pump (custom made by T. Homfeldt, UKE). An EPC-9 patch-clamp amplifier was used in combination with the PULSE stimulation and data aquisition software (HEKA, Lamprecht, Germany).

Solutions and chemicals. The modified KBR used in the tension studies contained (in mM): 118 NaCl, 4.75 KCl, 1.2 KH2PO4, 1.2 MgSO4, 2.5 CaCl2, 25 NaHCO3, and 11 D-glucose continuously gassed with carbogen to establish a pH of 7.3–7.4. For all electrophysiological experiments, the external Ringer solution contained (in mM): 140 NaCl, 5 KCl, 0.8 MgCl2, 1 CaCl2, 10 HEPES, and 5 glucose, with pH adjusted to 7.3 with NaOH. The standard pipette solution contained (in mM): 140 KCl, 2 MgCl2, 1 CaCl2, 10 HEPES, and 2.5 EGTA (EQCAL: 66 nM free Ca2+), with pH adjusted to 7.3 with KOH. For perforated-patch experiments, the whole amount of KCl was replaced by potassium gluconate (130 mM) and NaCl (10 mM). Nystatin [dissolved in dimethyl sulfoxide (DMSO)] was added to the pipette solution with a final concentration of 0.24 mg/ml. NS-1643 was a generous gift from NeuroSearch (Ballerup, Denmark), E-4031 from Eisai (Tokyo, Japan), haloperidol from Biotrend (Köln, Germany), and dofetilide from Pfizer (Sandwich, UK). Oxytocin (OT) was purchased from Bachem (Heidelberg, Germany), cisapride from Sigma, and thapsigargin from Alomone Labs. E-4031 and OT were dissolved in distilled water. Stocks of NS-1643, dofetilide, and haloperidol were prepared in DMSO, cisapride, and thapsigargin in ethanol. The solvents had no effect on epididymal contractile activity in their highest final concentration.

Data analysis. Experimental data are given as means ± SE, with n representing the number of cells or tissue samples derived from different animals. Student's two-tailed paired t-test was used to assess statistical significance (*P < 0.05 and **P < 0.01). Nonlinear regression analysis of isometric force data was used to create sigmoidal dose-response curves and to calculate EC50 values using GraphPad Prism 4 (GraphPad Software, San Diego, CA). Processing of the electrophysiological data was performed with PulseFit 8.65 (HEKA), Excel, and Sigma Plot 7.101. The voltage dependence of channel activation was fitted with a Boltzmann equation: y = 1/{1 + exp[–(V – V0.5)/k]}, where V0.5 is the potential of half-maximal erg current amplitude and k is the slope factor.


   RESULTS
TOP
 ABSTRACT
 METHODS
 RESULTS
DISCUSSION
 GRANTS
 REFERENCES
 
Effects of E-4031 and NS-1643 on epididymal contractility. Isometric force recordings were performed to investigate the functional role of erg channels in the epididymal duct. Under resting tone conditions, application of the selective erg channel blocker E-4031 enhanced spontaneous phasic contractions (SC) in both the caput (Fig. 1B) and the corpus epididymidis (Fig. 1Aa). At a concentration of 500 nM, a mean increase in SC amplitude by 51.3 ± 3.8% (n = 6, P < 0.05) and a mean reduction in SC frequency by 38.1 ± 4.3% (n = 6, P < 0.01) was observed in the proximal duct, when a steady state was approached. In Fig. 1Ab, the concentration-response relationship for E-4031 in the corpus region is shown, yielding EC50 values of 32 and 88 nM for the increase in SC amplitude and the decrease in SC frequency, respectively (n = 4). The SC modulatory effects of E-4031 were always accompanied by an abrupt and transient increase in tone particularly pronounced at the level of the caput.


Figure 1
View larger version (51K):
[in this window]
[in a new window]

  		Fig. 1. Contractile effects of E-4031 along the epididymal duct. Isometric force recordings showing typical effects of the human ortholog of ether-à-go-go-related gene (HERG) channel blocker E-4031 on spontaneous phasic activity at a concentration of 30 nM in the corpus (Aa) and at a concentration of 500 nM in the caput region (B). Ab: concentration-response relationship for E-4031 calculated on the ability to increase spontaneous phasic contraction (SC) amplitude and to decrease SC frequency in the corpus region. Data are means ± SE. C: effect of E-4031 on oxytocin (OT, 500 nM)-precontracted segments from the midcauda [cauda (m)].

 
In normally "quiescent" stretch-relaxed segments from the midcauda [cauda (m)] region, 500 nM E-4031 elicited a monophasic contraction within 10 min after application in 6 of 10 experiments (data not shown). OT (500 nM), which was recently found to evoke strong contraction in the epididymal cauda region (24), was applied at the end of each experiment to check intactness of the epididymal musculature. To test the ability of E-4031 to affect contraction in the cauda (m), the channel blocker was applied after application of OT (500 nM). As demonstrated in Fig. 1C, E-4031 (500 nM) reinforced the OT-induced contraction. This effect was consistently observed and characterized by an increase in contraction amplitude by 46.7 ± 3.9% (P < 0.01) and a decrease in contraction frequency by 33.8 ± 5.1% (n = 4). Interestingly, E-4031 never induced an increase in basal tone in cauda (m) segments.

To verify that an inhibition of erg channels underlies the E-4031 effects in the epididymal duct, we employed the class III antiarrhythmic agent dofetilide, the gastrointestinal prokinetic agent cisapride, and the dopamine receptor blocker haloperidol. All of these drugs have been shown to inhibit HERG channels (see Ref. 32 for review), and actually mimicked the effect of E-4031 in the corpus (Fig. 2, Aa and Ab). At a concentration of 500 nM, the respective increases in SC amplitude and decreases in SC frequency were 32.8 ± 4.% and 55.1 ± 2.1% for dofetilide (n = 3), 35.9 ± 2.9 and 42 ± 1.2% for cisapride (P < 0.01, n = 4), and 18.1 ± 2.7 and 33.2 ± 2.7% for haloperidol (P < 0.05, n = 3). In the cauda (m), application of 500 nM cisapride consistently induced phasic contractions without altering basal tone (n = 3; Fig. 2B).


Figure 2
View larger version (21K):
[in this window]
[in a new window]

  		Fig. 2. Effects of the ether-à-go-go-related gene (erg) channel blockers dofetilide and cisapride on epididymal contractility. Typical traces illustrating the contractile effects of dofetilide (Aa) in the corpus region as well as of cisapride at the level of the corpus (Ab) and the cauda (m) (B).

 
To investigate whether the mechanisms of E-4031-induced contraction in the epididymal duct require epithelial factors, experiments were performed with epithelium-denuded corpus segments that lacked phasic activity, as previously shown (23). At a concentration of 500 nM, the drug was able to elicit temporary contraction in these muscle preparations (n = 3; Fig. 3A), indicating localization and functional relevance of erg channels in the proximal duct peritubular muscle wall. Further pharmacological analysis using thapsigargin and nifedipine was carried out in another series of experiments with intact corpus segments to test the action on SMC calcium handling by E-4031. Figure 3Ba demonstrates that the SC modulatory effects of the blocker (500 nM) after prior application of the sarco(endo)plasmic reticulum (SR) Ca2+-ATPase (SERCA) pump inhibitor thapsigargin (2 µM, 20 min) were very similar compared with the control. The SC amplitude was increased by 52.8 ± 6.9% and the SC frequency decreased by 34.8 ± 2.9% (n = 4). However, E-4031 hardly affected the basal tone any more. The acute effects of thapsigargin consisted of a reduction in tone and SC amplitude, whereas cumulative application of the L-type Ca2+ channel blocker nifedipine (10 µM) had no effect on tone but totally suppressed phasic activity. Likewise, in the cauda (m), the excitatory effect of OT (500 nM)- and the E-4031 (500 nM)-induced amplification of OT-evoked contraction after prior application of thapsigargin (2 µM) resembled that in the control (Fig. 3Bb). The E-4031-induced increase in SC amplitude and decrease in SC frequency amounted to 52.8 ± 6.9% (P < 0.05) and 34.8 ± 2.9% (P < 0.05), respectively (n = 4). The channel blocker again did not affect basal tone; however, the OT-induced increase in tone was clearly reduced in the presence of the SR Ca2+ uptake inhibitor. Similar to its effect in the corpus, nifedipine (10 µM) totally suppressed rhythmic activity in the cauda (m) without significantly affecting tone. The same nifedipine effects were observed without prior application of thapsigargin (n = 4, data not shown).


Figure 3
View larger version (21K):
[in this window]
[in a new window]

  		Fig. 3. Mechanisms of E-4031-induced contraction. A: representative effect of E-4031 in epithelium-denuded corpus segments that lacked SC. B: force recordings demonstrating the excitatory effects of E-4031 after prior application of thapsigargin (2 µM) and the inhibitory effect of additionally applied nifedipine (10 µM) in the corpus (Ba) and in OT (500 nM)-precontracted cauda (m) segments (Bb).

 
In the following, we studied the effects of the HERG channel activator NS-1643 on epididymal spontaneous and agonist-induced contractions. As demonstrated in Fig. 4, Aa and B, 30 µM of the drug totally suppressed spontaneous contractility in both the corpus (n = 6) and the caput region (n = 4) within 10 min after application. The EC50 value for NS-1643-induced suppression of phasic contractile amplitude in the corpus was 8.3 µM (n = 4; see Fig. 4Ab). To test whether erg channel activation could also affect receptor-mediated contraction, we investigated the effect of NS-1643 on OT-prestimulated cauda (m) segments. As shown in Fig. 4C, application of 30 µM NS-1643 resulted in an abrupt and persisting suppression of the OT (500 nM)-induced rhythmic activity, again accompanied by a decrease in basal tone.


Figure 4
View larger version (32K):
[in this window]
[in a new window]

  		Fig. 4. Effects of NS-1643 on epididymal duct contractility. Modulation of spontaneous phasic activity by the HERG channel activator NS-1643 (30 µM) in the caput (B) and corpus region (Aa) determined by isometric force recording. Ab: concentration-response curve for the relative decrease in phasic contractile amplitudes evoked by NS-1643 in the corpus within 10 min after application. Data are means ± SE. C: original trace illustrating the effect of NS-1643 (30 µM) on OT (500 nM)-prestimulated cauda (m) segments.

 
Epididymal expression of erg1 protein and transcripts. Western blotting was performed to confirm the presence of erg1 proteins in the epididymal duct. An antibody against the COOH-terminal peptide fragment of erg1 described by Pond et al. (30) was used to detect putative erg1a and erg1b subunits. Comparative immunoblotting assays clearly demonstrated erg1 protein expression in membrane fractions of all duct regions (n = 3). As shown in Fig. 5Aa, the anti-erg1 antibody recognized bands at ~160 kDa and at ~135 kDa, consistent with the estimated sizes of glycosylated and unglycosylated erg1a, respectively. In the corpus preparation, an additional band at ~170 kDa was detected. Moreover, immunoreactivity for erg1 was associated with a protein of ~90 kDa, possibly representing the b-erg1b subunit, an NH2-terminal splice variant of the erg1. Because in the caput and corpus region the putative erg1b band was clearly more marked than those of erg1a, a predominance of the erg1b isoform in the proximal epididymal duct is possible.


Figure 5
View larger version (46K):
[in this window]
[in a new window]

  		Fig. 5. Epididymal expression of erg channel subunits. A: Western blots of bovine and rat epididymal duct samples of the regions indicated and of erg1a- or erg1b-expressing Chinese hamster ovary (CHO) cells. Fractionated membrane protein preparations (50 µg) were incubated with an antibody against the erg1 COOH terminus. Molecular weight markers are indicated at the left, and the position of putative erg1 subunit positive bands in the duct are marked by arrowheads. Aa: proteins close to the expected size of unglycosylated erg1b (~90 kDa) as well as unglycosylated and glycosylated erg1a (~135 and ~160 kDa) were detected in all bovine epididymal duct regions. In the corpus, an additional ~170-kDa protein was found, which was also present in both rat epididymal preparations. Here and in the transfected CHO cells, immunoreactivity is associated with further proteins of different sizes, possibly representing different glycosylation forms of the splice variants erg1a and erg1b (Ab). B: immunohistochemical analysis of erg1 expression in epididymal cross sections from the corpus region using the anti-erg1 antibody revealed immunoreactivity in the epididymal muscle wall (large arrow) and epithelial principal cells (asterisk) as well as associated blood vessels (small arrow). Inset: negative control with the primary antibody omitted. E, epithelium. Scale bars: 50 µm. C: detection of mRNA transcripts for bovine (b)-erg1a and b-erg1b channel subunits in the bovine epididymal duct by RT-PCR. DNA fragments could be detected after agarose gel electrophoresis of 10% of the PCR reaction products using caput, corpus, and cauda (m) cDNAs as template. D: RT-PCR analysis of epididymal erg channel expression by the use of specific primer pairs for b-erg1 (lanes 1, 4, and 7), b-erg2 (lanes 2, 5, and 8), or b-erg3 cDNA (lanes 3, 6, and 9). Specific bands of 590 bp could be detected only with the b-erg1 primer pair in all duct regions.

 
Membrane fractions of the rat epididymal caput and cauda region as well as CHO cells transfected with erg1a or erg1b cDNA were used as positive controls and markers for the expected protein size of the erg1 subunits (Fig. 5Ab). In preparations of the CHO cells, single protein bands at the expected sizes of partially glycosylated erg1a (155 kDa) and glycosylated erg1b (~105 kDa) were detected. In the rat epididymal fractions, a ~114-kDa protein, probably representing a glycosylation form of the erg1b splice variant, and again a ~170-kDa protein were found. In addition, the antibody detected single bands at positions expected for unglycosylated erg1a (~135 kDa) in the cauda and for partially glycosylated erg1a (~145 kDa) in the caput region.

Immunohistochemical analysis was used to investigate the cellular distribution of erg1 protein in cross sections from all bovine epididymal duct regions. As shown for the corpus in Fig. 5B, immunoreactivity against the anti-erg1 antibody could be localized to the epididymal smooth muscle and epithelial principal cells as well as to associated blood vessels all along the duct. No staining was seen when the primary antibody was omitted.

To verify the molecular identity of the erg channel subunits in the bovine epididymal duct, conventional RT-PCR was performed using cDNA preparations from the caput, corpus, and cauda region as template. First, specific primers for the bovine erg1a and erg1b splice variants, b-erg1a and b-erg1b, were applied. As demonstrated in Fig. 5C, mRNA transcripts for both subunits were detected in all duct regions. We then examined the epididymal expression of all three erg channels. Specific primer pairs designed to detect transcripts of the bovine erg genes (b-erg1, b-erg2, and b-erg3) were used. Figure 5D shows that mRNA transcripts of the erg1 gene (590 bp) were easily found in all duct regions, whereas erg2 and erg3 signals could not be detected in the epididymis.

Effects of NS-1643 on rerg1b currents. Because erg1b is highly expressed in the epididymis and NS-1643 effects have only been described for the erg1a isoform (4, 11) and most recently for erg2 (7), we examined the effects of the erg channel activator on erg1b currents using HEK-293 cells as a heterologous expression system. Electrophysiological investigation of native erg channels turned out to be not feasible, which might be due to the strong dissociation procedure necessary to free the epididymal contractile cells from the substantial amount of connective tissue present in the lamina propria.

With the use of the conventional whole cell technique, modulation of erg1b activation by NS-1643 was investigated by 4-s depolarizing pulses to +40 mV followed by repolarization to –40 mV for 5 s from a holding potential of –80 mV every 20 s (Fig. 6A). Application of 10 µM NS-1643 resulted in a huge current increase. At the end of the experiment, E-4031 (10 µM) was applied, which resulted in a complete blockage of the erg current, confirming that NS-1643 specifically affected erg1b. The tail currents induced upon repolarization to –40 mV are also shown on expanded time scales. They are due to the fast recovery from inactivation followed by slower deactivation of the erg channels (36). The time course of the NS-1643 effect is illustrated in Fig. 6B. The erg1b peak tail current amplitude before and after application of 10 µM NS-1643 is given as a function of time, demonstrating a considerable current increase within 10 min after application of the channel activator. Figure 6C shows that the tail currents increased at all tested concentrations of the stimulator. The percentage of increase was 70 ± 8.5% (n = 4, P < 0.05) with 1 µM, 286 ± 31.4% (n = 7, P < 0.01) with 10 µM, and 237 ± 26.9% (n = 3, P < 0.05) with 30 µM NS-1643, indicating saturation in erg1b current increment in the range of 10–30 µM. By contrast, the steady-state current at +40 mV was not consistently increased.


Figure 6
View larger version (25K):
[in this window]
[in a new window]

  		Fig. 6. Modulation of erg currents by NS-1643 in HEK-293 cells heterologously expressing erg1b channels. A pulse protocol consisting of a depolarization to +40 mV for 4 s followed by a 5-s voltage step to –40 mV was applied every 20 s from a holding potential of –80 mV (see pulse diagram). In A, current traces are shown before and after application of 10 µM NS-1643 and 10 µM E-4031. Dotted lines indicate zero current level. Tail currents, which could be identified by their typical hook-like shape, are also shown on expanded time scale. B: time course of erg tail current increase induced by 10 µM NS-1643. Peak tail current amplitudes were measured as depicted in A. Specificity of erg current was confirmed by addition of 10 µM E-4031 (A and B). C: percentage of increase in peak tail currents elicited at repolarization to –40 mV as a function of NS-1643 concentration ([NS-1643]) recorded in the conventional (filled bars) and perforated-patch (p-p; open bar) whole cell configuration. Data are means ± SE; no. of experiments indicated in brackets. In C, statistical significance vs. control is expressed as *P < 0.05 and **P < 0.01 by Student's 2-tailed paired t-test.

 
To determine the effect of NS-1643 on the voltage dependence of erg1b current activation, erg currents were elicited with varying depolarizing pulses of 4-s duration before and after drug application. Starting from a holding potential of –60 mV, the HEK cells were clamped to –80 mV for 1 s. Test pulses to potentials between –80 and 60 mV were followed by a constant pulse to –40 mV for 5 s (Fig. 7Ab). When using 30 µM NS-1643, the cells were held at –80 mV, and test pulses ranged from –100 to 60 mV, since at this concentration the activator already evoked erg currents at –80 mV. Representative examples of rerg1b current families elicited under control conditions and in the presence of 1 and 30 µM NS-1643 are shown in Fig. 7, Aa and Ab, respectively. In control experiments, outward currents were activated by depolarization to potentials more positive than about –40 mV. The amplitude of these currents increased with depolarizations up to 10 mV and then declined, resulting in a crossing of current traces at more positive potentials. After drug application, the activation threshold was shifted to more negative potentials.


Figure 7
View larger version (30K):
[in this window]
[in a new window]

  		Fig. 7. Effects of NS-1643 on the voltage dependence of erg1b current activation. A: membrane currents were recorded in the whole cell configuration in HEK-293 cells heterologously expressing erg1b channels. Erg current activation was assessed by 4-s depolarizing test pulses to potentials between –80 mV (or –100 mV in case of experiments with 30 µM NS-1643) and +60 with 10-mV increments, followed by a constant pulse to –40 mV for 5 s (see pulse diagram). Families of erg currents were recorded before and after application of 1 µM (Aa) and 10 and 30 µM NS-1643 (Ab). Dotted lines indicate zero current level. Ba: normalized maximal erg1b tail current amplitudes as a function of the preceding test pulse potential in the absence and presence of different concentrations of NS-1643. Data points were fitted with a Boltzmann function yielding the potentials of half-maximal activation (V0.5; see text for details). Bb: shift in V0.5 values of erg1b currents as a function of [NS-1643] recorded in the conventional (filled bars) and perforated-patch (p-p; open bar) whole cell configuration. Data are mean ± SE; no. of experiments indicated. In Bb, statistical significance vs. control is expressed as *P < 0.05 and **P < 0.01 by Student's 2-tailed paired t-test.

 
The tail current amplitudes recorded at the constant repolarizing pulse to –40 mV were normalized and plotted against the prepulse potential, yielding the isochronal activation curve of the erg1b current. A Boltzmann function was fitted to the data yielding the potential at which the erg1b channels were half maximally activated. At all tested activator concentrations, the current-voltage curves were significantly shifted to negative potentials (see Fig. 7, Ba and Bb). The V0.5 values and slope factors determined were –0.6 ± 1.8 and 10.5 ± 0.3 mV for control (n = 14), –10.5 ± 2 and 12.2 ± 1.9 mV for 1 µM NS-1643 (n = 4), –29.5 ± 6 and 12.2 ± 2.3 mV for 10 µM NS-1643 (n = 7), and –62.8 ± 3.4 and 11 ± 3.7 mV for 30 µM NS-1643 (n = 3).

Perforated-patch recordings confirmed the effects of 10 µM NS-1643 on erg1b current activation measured in the conventional whole cell mode. As demonstrated in Fig. 6C, the mean peak tail current amplitude increased by 164 ± 82% (n = 6, P < 0.05). Likewise, the current-voltage curve was significantly shifted to negative potentials. The V0.5 values and slope factors determined were –3.2 ± 1.4 and 11.1 ± 0.4 mV in the control vs. –44.9 ± 4.6 and 9.8 ± 0.6 mV after application of the channel activator (n = 11, P < 0.01; Fig. 7Bb).


   DISCUSSION
TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
GRANTS
 REFERENCES
 
The present study provides strong evidence for the expression of erg1 channels in the bovine epididymal duct and suggests an important role for erg1 currents in the control of electrical and mechanical activity in epididymal smooth muscle. Functional significance of erg channels was demonstrated by the excitatory effect of E-4031 and other known HERG blockers as well as by the inhibitory effect of NS-1643 on contractility all along the duct. RT-PCR and immunological approaches allowed amplification of erg1 mRNA transcripts and confirmed functional translation and successful incorporation into the membrane of both erg1 isoforms, erg1a and erg1b, in all duct regions. Using HEK-293 cells as a expression system, erg1b currents showed to be activated by NS-1643 in a unique voltage- and concentration-dependent manner.

Effects of blocking and activating erg channels. The selective erg channel blocker E-4031 exerted excitatory effects on the SC amplitude and inhibitory effects on SC frequency in the epididymal duct. The half-maximal effects of the methanesulfonanilide in the epididymal corpus region were 32 and 88 nM, which is in the range of the EC50 values reported previously for native erg channels (1, 28). Cisapride, dofetilide, and haloperidol, which have all been reported to block HERG (32), mimicked the contractile effects of E-4031, pointing to erg channels as a direct target and effector molecule of the drugs. The E-4031-induced concentration-dependent increase in epididymal SC amplitude may reflect an increase in action potentials per "slow wave." E-4031 also increased the amplitude of spontaneous contractions in the guinea pig urinary bladder (14) and the rabbit small intestine (18), whereas in the human jejunum, high concentrations of the compound (1 µM) replaced phasic contractions with small tonic contractures due to the elimination of slow waves (8). The mechanism of the E-4031-evoked reduction in epididymal SC frequency is unknown, but the phenomenon equals the findings in the portal vein. Here, a block of erg channels is suggested to delay action potential repolarization and to decrease the activity of hyperpolarization-activated pacemaker channels, thereby prolonging intercontraction intervals (28).

E-4031 induced transient contraction in epithelium-denuded corpus segments, which lacked spontaneous phasic activity. The latter concurs with previous findings supporting a crucial role of epididymal epithelial factors for the generation of SC in the proximal duct (23). Moreover, E-4031 evoked monophasic and amplified OT-induced contraction in normally quiescent cauda (m) segments. In conjunction with the immunohistochemical localization of erg1 protein to the epididymal muscle wall, it seems likely that E-4031 depolarizes the resting potential in epididymal SMC, thereby increasing their excitability.

All spontaneous and OT-/E-4031-induced rhythmic activity in the epididymal duct was totally suppressed by nifedipine, pointing to an essential role of L-type Ca2+ channels in the generation of phasic contractions. An E-4031-dependent induction of SC was also observed in the quiescent esophageal circular smooth muscle, presumably due to an increase in intracellular Ca2+ concentration following the opening of voltage-dependent Ca2+ channels (1). By contrast, inhibition of SERCA pumps with thapsigargin showed to have no effect on OT-/E-4031-induced rhythmic contractions and only slightly reduced the SC amplitude, indicating that SR Ca2+ release is not obligatory for the induction and maintenance of epididymal rhythmic activity. Because the SR Ca2+ uptake inhibitor induced a loss of tone in the proximal duct and reduced the OT-induced increase in tone in the cauda (m), a tone-relevant role of SR Ca2+ release can be assumed. However, it remains to be elucidated why E-4031 affected basal tone only in the proximal duct and why the blocker produced only monophasic contraction in the cauda (m) when administered alone. Possibly, these data reflect regionally different actions of E-4031 on SMC Ca2+ handling and a higher threshold of excitability in the cauda region.

The SC-suppressive effects of NS-1643 confirmed the presence and functional role of erg channels in the epididymal duct. The EC50 value (8.3 µM) determined for the reduction in SC amplitude in the corpus was very similar to that found for HERG channel activation in oocytes (10.5 µM; see Ref. 11). At a concentration of 30 µM, the erg channel activator totally suppressed spontaneous rhythmic activity in the proximal duct regions as well as the OT-induced contraction in cauda (m) segments. This effect was unexpected in view of the fact that NS-1643 increases HERG currents by shifting the steady-state inactivation curve to more depolarized potentials without altering the activation threshold (4).

Epididymal expression of erg channel subunits. The results of the Western blots suggest the presence of the erg1 splice variants erg1a and erg1b in all regions of the bovine epididymal duct. The partially varying molecular weights of the erg1 subunits found in the rat and CHO preparations could indicate differences with respect to protein glycosylation or splicing of the erg1 gene product. In addition, nonspecific binding of the used anti-erg1 antibody as well as posttranslational protein modifications other than glycosylation may account for a subset of the additional bands seen in the bovine and rat native tissue compared with transfected CHO cells. The higher expression level of the putative erg1b isoform compared with that of erg1a in the epididymal proximal duct regions may point to a relatively higher portion of homomultimeric erg1b channels or a higher percentage of erg1b subunits in heteromultimeric channels. A marked predominance of erg1b over erg1a transcripts was also detected in portal vein myocytes (28). Erg1a and erg1b have been shown to be coexpressed in several tissues (9, 12, 19, 21, 28) and to form heteromultimeric channels in the heart (15). Heteromeric erg1 channels significantly differ from homomeric erg1 channels in their response to hormonal stimuli (16) and biophysical properties, such as the deactivation kinetics and steady-state inactivation (19, 21).

RT-PCR analyses by the use of specific erg primers, allowed amplification of mRNA transcripts for b-erg1, however, not for the two other Kv.11 family members b-erg2 and b-erg3 in the epididymis. The presence of erg1 mRNA has also been reported for other smooth muscles such as the esophagus, stomach, duodenum and urinary bladder (27), the portal vein (28), and the gallbladder (29). In accordance with the present findings, erg3 gene transcripts were absent from all of these tissues. Likewise, expression of erg2, which is also suggested to be widely brain-specific (35), was only detected in the gastric antrum (27). Interestingly, no RT-PCR signals of all erg subtypes could be detected in preparations from the rat vas deferens (27).

NS-1643 effects on heterologously expressed erg1b channels. NS-1643 has been described to enhance HERG (erg1a) currents by shifting the steady-state inactivation curve to more positive potentials without affecting the voltage dependence of activation (4, 11). Because our present results indicate a considerable epididymal expression of erg1b subunits and because erg1b channels exhibit less inactivation than erg1a (16), we examined the effects of NS-1643 on erg1b channels using HEK-293 cells as a mammalian heterologous expression system. Surprisingly, the effects of NS-1643 on the erg1b isoform were much more pronounced than those exerted on HERG channels. In addition, the activator-induced changes in the biophysical properties turned out to be completely different, since NS-1643 increased erg1b currents by a marked leftward shift in the voltage dependence of channel activation. A qualitatively similar NS-1643 effect was recently reported for erg2 channels, where 30 µM NS-1643 shifted the voltage for half-maximal channel activation by ~6 mV to the left (7). In contrast, the drug-induced leftward shift in erg1b channel activation found in the present study amounted to ~60 mV, resulting in an activation threshold even below –80 mV in the presence of 30 µM NS-1643. This finding can readily explain the inhibitory effects of the drug on epididymal myogenic activity. A NS-1643-induced hyperpolarization due to increased erg conductance would inhibit the activation of voltage-dependent Ca2+ channels obligatory for the induction of epididymal phasic activity (23). The same mechanism of action could account for the total suppression of OT-induced contraction in the cauda produced by the drug. However, a direct antagonistic effect of NS-1643 on voltage-gated Ca2+ channels cannot totally be excluded, although neither L-type nor T-type calcium channel currents were found to be affected by 10 µM NS-1643 in guinea pig ventricular myocytes (11).

Putative functional role of erg channels. The data of the present study indicate a functional role for erg1 channels in the regulation of epididymal motility patterns and therefore sperm transport. The presence and functional role of inwardly rectifying, E-4031-sensitive erg K+ currents has already been shown in various tissues of the gastrointestinal tract (1, 8, 20), the gallbladder (29), and the portal vein (28). It is generally accepted that the concentration-dependent modulation of electrical and mechanical activity by E-4031 in smooth muscle is connected with the fundamental importance of erg currents for the control of the resting membrane potential. In interstitial cells of Cajal, erg channels are supposed to be the most important K+ channels regulating cellular excitability (41). Pacemaker-like cells are also suspected to be present in those epididymal duct regions that exhibit spontaneous activity (23), and they may form a target of the E-4031 effects observed in the present study. Ohya et al. (28) suggest that erg channels are crucial for smooth muscles that frequently discharge action potentials, whereas in quiescent blood vessels other K+ currents are more important. In fact, in gallbladder myocytes, erg1 channels seem to serve a similar function as the rapidly activating inward-rectifying IKr in cardiac muscle (31, 40) by contributing to the repolarization of the plateau phase of action potentials (29).

Perspectives and Significance

Inhibition and activation of erg channels resulted in marked changes in epididymal duct motility. Controlled passage of sperm through the duct depends on its phasic activity and is of critical importance for sperm maturation (22, 26, 37). Because erg channels are targets for many pharmaceutics and hormonal regulation, mostly resulting in decreased channel activity (2, 3, 33), it is tempting to speculate that erg channel modulation by drug intake interferes with sperm quality and male fertility. Especially, the ability of erg channel activation to suppress duct peristalsis raises the question about a potential contraceptive significance of erg channel modulators. However, because erg1 channels are crucial for normal cardiac function (32), an epididymis-restricted effect of a given erg channel modulator must be a prerequisite for its potential therapeutic use in male contraception.


   GRANTS
TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
REFERENCES
 
This work was supported by Grant SFB444/A3 from the Deutsche Forschungsgemeinschaft.


   ACKNOWLEDGMENTS
 
We thank Telse Kock and Annett Hasse for expert technical help.


   FOOTNOTES
 

Address for reprint requests and other correspondence: M. Mewe, Institute of Vegetative Physiology and Pathophysiology, UKE, Martinistr. 52, D-20246 Hamburg, Germany (e-mail: mewe{at}uke.uni-hamburg.de)

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.


   REFERENCES
TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 

  1. Akbarali HI, Thatte H, He XD, Giles WR, Goyal RK. Role of HERG-like K+ currents in opossum esophageal circular smooth muscle. Am J Physiol Cell Physiol 277: C1284–C1290, 1999.[Abstract/Free Full Text]
  2. Barros F, Gómez-Varela D, Viloria CG, Palomero T, Giráldez T, de la Peña T. Modulation of human erg K+ channel gating by activation of a G-protein-coupled receptor and protein kinase C. J Physiol 511: 333–346, 1998.[Abstract/Free Full Text]
  3. Bauer CK. The erg inwardly rectifying K+ current and its modulation by thyrotropin-releasing hormone in giant clonal rat anterior pituitary cells. J Physiol 510: 63–70, 1998.[Abstract/Free Full Text]
  4. Casis O, Olesen SP, Sanguinetti MC. Mechanism of action of a novel human ether-a-go-go-related gene channel activator. Mol Pharmacol 69: 658–665, 2006.[Abstract/Free Full Text]
  5. Clark RB, Mangoni ME, Lueger A, Couette B, Nargeot J, Giles WR. A rapidly activating delayed rectifier K+ current regulates pacemaker activity in adult mouse sinoatrial node cells. Am J Physiol Heart Circ Physiol 286: H1757–H1766, 2004.[Abstract/Free Full Text]
  6. Davidoff MS, Schulze W. Combination of the peroxidase-anti-peroxidase (PAP)- and avidin-biotin-peroxidase complex (ABC)-techniques: an amplification alternative in immuncytochemical staining. Histochemistry 93: 531–536, 1990.[CrossRef][Web of Science][Medline]
  7. Elmedyb P, Olesen SP, Grunnet M. Activation of ERG2 potassium channels by the diphenylurea NS1643. Neuropharmacology 53: 283–94, 2007.[CrossRef][Medline]
  8. Farrelly AM, Ro S, Callaghan BP, Khoyi MA, Fleming N, Horowitz B, Sanders KM, Keef KD. Expression and function of KCNH2 (HERG) in the human jejunum. Am J Physiol Gastrointest Liver Physiol 284: G883–G895, 2003.[Abstract/Free Full Text]
  9. Guasti L, Cilia E, Crociani O, Hofmann G, Polvani S, Becchetti A, Wanke E, Tempia F, Arcangeli A. Expression pattern of the ether-a-go-go-related (ERG) family proteins in the adult mouse central nervous system: evidence for coassembly of different subunits. J Comp Neurol 491: 157–174, 2005.[CrossRef][Web of Science][Medline]
  10. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflügers Arch 391: 85–100, 1981.[CrossRef][Web of Science][Medline]
  11. Hansen RS, Diness TG, Christ T, Demnitz J, Ravens U, Olesen SP, Grunnet M. Activation of human ether-a-go-go-related gene potassium channels by the diphenylurea 1,3-Bis-(2-hydroxy-5-trifluoromethyl-phenyl)-urea (NS1643). Mol Pharmacol 69: 266–277, 2006.[Abstract/Free Full Text]
  12. Hirdes W, Schweizer M, Schuricht KS, Guddat SS, Wulfsen I, Bauer CK, Schwarz JR. Fast erg K+ currents in rat embryonic serotonergic neurones. J Physiol 564: 33–49, 2005.[Abstract/Free Full Text]
  13. Horn R, Marty A. Muscarinic activation of ionic currents measured by a new whole-cell recording method. J Gen Physiol 92: 145–159, 1988.[Abstract/Free Full Text]
  14. Imai T, Okamoto T, Yamamoto Y, Tanaka H, Koike K, Shigenobu K, Tanaka Y. Effects of different types of K+ channel modulators on the spontaneous myogenic contraction of guinea-pig urinary bladder smooth muscle. Acta Physiol Scand 173: 323–333, 2001.[CrossRef][Web of Science][Medline]
  15. Jones EM, Roti Roti EC, Wang J, Delfosse SA, Robertson GA. Cardiac IKr channels minimally comprise hERG1a and 1b subunits. J Biol Chem 279: 44690–44694, 2004.[Abstract/Free Full Text]
  16. Kirchberger NM, Wulfsen I, Schwarz JR, Bauer CK. Effects of TRH on heteromeric rat erg1a/1b K+ channels are dominated by the rerg1b subunit. J Physiol 571: 27–42, 2006.[Abstract/Free Full Text]
  17. Kuriyama H, Kitamura H, Itoh T, Inoue R. Physiological features of visceral smooth muscle cells, with special reference to receptors and ion channels. Physiol Rev 78: 811–920, 1998.[Abstract/Free Full Text]
  18. Lamarca V, Grasa L, Fagundes DS, Arruebo MP, Plaza MA, Murillo MD. K+ channels involved in contractility of rabbit small intestine. J Physiol Biochem 62: 227–236, 2006.[Medline]
  19. Lees-Miller JP, Kondo C, Wang L, Duff HJ. Electrophysiological characterization of an alternatively processed ERG K+ channel in mouse and human hearts. Circ Res 81: 719–726, 1997.[Abstract/Free Full Text]
  20. Lillich JD, Rakestraw PC, Roussel AJ, Finley MR, Ganta S, Freeman LC. Expression of the ether-a-go-go (ERG) potassium channel in smooth muscle of the equine gastrointestinal tract and influence on activity of jejunal smooth muscle. Am J Vet Res 64: 267–272, 2003.[CrossRef][Web of Science][Medline]
  21. London B, Trudeau MC, Newton KP, Beyer AK, Copeland NG, Gilbert DJ, Jenkins NA, Satler CA, Robertson GA. Two isoforms of the mouse ether-a-go-go-related gene coassemble to form channels with properties similar to the rapidly activating component of the cardiac delayed rectifier K+ current. Circ Res 81: 870–878, 1997.[Abstract/Free Full Text]
  22. Mewe M, Bauer CK, Müller D, Middendorff R. Regulation of spontaneous contractile activity in the bovine epididymal duct by cyclic guanosine 5'-monophosphate-dependent pathways. Endocrinology 147: 2051–2062, 2006.[Abstract/Free Full Text]
  23. Mewe M, Bauer CK, Schwarz JR, Middendorff R. Mechanisms regulating spontaneous contractions in the bovine epididymal duct. Biol Reprod 75: 651–659, 2006.[Abstract/Free Full Text]
  24. Mewe M, Wulfsen I, Middendorff R, Bauer CK. Differential modulation of epididymal activity by oxytocin and noradrenaline. Reproduction 134: 493–501, 2007.[Abstract/Free Full Text]
  25. Middendorff R, Müller D, Wichers S, Holstein AF, Davidoff MS. Evidence for production and functional activity of nitric oxide (NO) in seminiferous tubules and blood vessels of the human testis. J Clin Endocrinol Metab 82: 4154–4161, 1997.[Abstract/Free Full Text]
  26. Moore HDM. Post-testicular sperm maturation and transport in the excurrent ducts. In: Gametes - The Spermatozoon, edited by Grudzinskas JG and Yovich JL. Cambridge, UK: Cambridge Univ Press, 1995.
  27. Ohya S, Asakura K, Muraki K, Watanabe M, Imaizumi Y. Molecular and functional characterization of ERG, KCNQ, and KCNE subtypes in rat stomach smooth muscle. Am J Physiol Gastrointest Liver Physiol 282: G277–G287, 2002.[Abstract/Free Full Text]
  28. Ohya S, Horowitz B, Greenwood IA. Functional and molecular identification of ERG channels in murine portal vein myocytes. Am J Physiol Cell Physiol 283: C866–C877, 2002.[Abstract/Free Full Text]
  29. Parr E, Pozo MJ, Horowitz B, Nelson MT, Mawe GM. ERG K+ channels modulate the electrical and contractile activities of gallbladder smooth muscle. Am J Physiol Gastrointest Liver Physiol 284: G392–G398, 2003.[Abstract/Free Full Text]
  30. Pond AL, Scheve BK, Benedict AT, Petrecca K, Van Wagoner DR, Shrier A, Nerbonne JM. Expression of distinct ERG proteins in rat, mouse, and human heart. J Biol Chem 275: 5997–6006, 2000.[Abstract/Free Full Text]
  31. Sanguinetti MC, Jiang C, Curran ME, Keating MT. A mechanistic link between an inherited and an acquired cardiac arrythmia: HERG encodes the IKr potassium channel. Cell 81: 299–307, 1995.[CrossRef][Web of Science][Medline]
  32. Sanguinetti MC, Tristani-Firouzi M. hERG potassium channels and cardiac arrhythmia. Nature 440: 463–469, 2006.[CrossRef][Web of Science][Medline]
  33. Schledermann W, Wulfsen I, Schwarz JR, Bauer CK. Modulation of rat erg1, erg2, erg3 and HERG K+ currents by thyrotropin-releasing hormone in anterior pituitary cells via the native signal cascade. J Physiol 532: 143–163, 2001.[Abstract/Free Full Text]
  34. Schwarz JR, Bauer CK. Functions of erg K+ channels in excitable cells. J Cell Mol Med 8: 22–30, 2004.[Web of Science][Medline]
  35. Shi W, Wymore RS, Wang HS, Pan Z, Cohen IS, McKinnon D, Dixon JE. Identification of two nervous system-specific members of the erg potassium channel family. J Neurosci 17: 9423–9432, 1997.[Abstract/Free Full Text]
  36. Smith PL, Baukrowitz T, Yellen G. The inward rectification mechanism of the HERG cardiac potassium channel. Nature 379: 833–836, 1996.[CrossRef][Web of Science][Medline]
  37. Sullivan R, Frenette G, Girouard J. Epididymosomes are involved in the acquisition of new sperm proteins during epididymal sperm transit. Asian J Androl 9: 483–491, 2007.[CrossRef][Medline]
  38. Trudeau MC, Warmke JW, Ganetzky B, Robertson GA. HERG, a human inward rectifier in the voltage-gated potassium channel family. Science 269: 92–95, 1995.[Abstract/Free Full Text]
  39. Warmke JW, Ganetzky B. A family of potassium channel genes related to eag in Drosophila and mammals. Proc Natl Acad Sci USA 91: 3438–3442, 1994.[Abstract/Free Full Text]
  40. Wettwer E, Scholtysik G, Schaad A, Himmel H, Ravens U. Effects of the new class III antiarrhythmic drug E-4031 on myocardial contractility and electrophysiological parameters. J Cardiovasc Pharmacol 17: 480–487, 1991.[Web of Science][Medline]
  41. Zhu Y, Golden CM, Ye J, Wang XY, Akbarali HI, Huizinga JD. ERG K+ currents regulate pacemaker activity in ICC. Am J Physiol Gastrointest Liver Physiol 285: G1249–G1258, 2003.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
 J. Physiol.Home page
I. A. Greenwood, S. Y. Yeung, R. M. Tribe, and S. Ohya
Loss of functional K+ channels encoded by ether-à-go-go-related genes in mouse myometrium prior to labour onset
J. Physiol., May 15, 2009; 587(10): 2313 - 2326.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
S.-N. Wu, H. Peng, B.-S. Chen, Y.-J. Wang, P.-Y. Wu, and M.-W. Lin
Potent Activation of Large-Conductance Ca2+-Activated K+ Channels by the Diphenylurea 1,3-Bis-[2-hydroxy-5-(trifluoromethyl)phenyl]urea (NS1643) in Pituitary Tumor (GH3) Cells
Mol. Pharmacol., December 1, 2008; 74(6): 1696 - 1704.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
294/3/R895    most recent
00521.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mewe, M.
Right arrow Articles by Bauer, C. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mewe, M.
Right arrow Articles by Bauer, C. K.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.